Почетна › Srpastoćelijska bolest › Džordžija
Kliničke studije za Srpastoćelijska bolest u državi Džordžija
23 studija za Srpastoćelijska bolest traži učesnike na lokacijama u državi Džordžija.
Gradovi u državi Džordžija
Zvanični tekst studije (na engleskom)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Emory University, Atlanta
- Augusta University, Augusta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07187973A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Augusta University Georgia, Augusta
- WCG Sonar Clinical Research, Riverdale
Тражи се учесникФаза 3
Узраст од 12 до 100 · Оба пола · Ажурирано 10. 11. 2026. · NCT06439082Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
- Emory University, Atlanta
Тражи се учесникФаза 4
Узраст од 18 до 50 · Жене · Ажурирано 5. 11. 2026. · NCT06665997Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07224360Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
- Children's Hospital of Atlanta: Eagelston, Atlanta
Тражи се учесник
Узраст од 7 до 18 · Оба пола · Ажурирано 22. 10. 2026. · NCT07090668Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Children's Healthcare of Atlanta, Atlanta
Тражи се учесник
Узраст од 16 до 39 · Оба пола · Ажурирано 8. 10. 2026. · NCT06374238Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06699849A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Children's Healthcare Atlanta, Atlanta
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Healthcare Atlanta, Atlanta
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT06612268Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
- Children's Healthcare of Atlanta, Atlanta
Тражи се учесник
Узраст од 8 до 18 · Оба пола · Ажурирано 10. 9. 2026. · NCT07562451A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Children's Center for Advanced Pediatrics, Atlanta
Тражи се учесникФаза 2/3
Узраст 12 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT05431088A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Winship Cancer Institute of Emory University, Atlanta
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
- Memorial Health University Medical Center, Savannah
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 17. 8. 2026. · NCT04398628Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Тражи се учесникФаза 1/2
Узраст од 7 до 21 · Оба пола · Ажурирано 29. 7. 2026. · NCT02447874Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Augusta University Georgia, Augusta
Тражи се учесникФаза 4
6 Months – 100 Years · Оба пола · Ажурирано 8. 6. 2026. · NCT04657822Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
- Children's Healthcare of Atlanta, Atlanta
Тражи се учесникФаза 1/2
Узраст од 12 до 45 · Оба пола · Ажурирано 4. 6. 2026. · NCT07252050Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's Healthcare of Atlanta (MRD-HCT), Atlanta
Тражи се учесникОпсервациона студија
Узраст од 3 до 20 · Оба пола · Ажурирано 4. 6. 2026. · NCT06941389A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Children's Healthcare of Atlanta, Atlanta
Тражи се учесник
Узраст од 13 до 21 · Оба пола · Ажурирано 11. 5. 2026. · NCT06290401Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400006, Atlanta
- Site # 8400002, Atlanta
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 15. 4. 2026. · NCT07247188A Long-term Follow-up Study in Patients Who Received BEAM-101
- Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
Тражи се учесникОпсервациона студија
Узраст од 14 до 37 · Оба пола · Ажурирано 28. 1. 2026. · NCT07373639Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- Augusta University, Augusta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 1. 2026. · NCT01245179Integrative Training Program for Pediatric Sickle Cell Pain
- Children's Healthcare of Atlanta, Atlanta
- Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Тражи се учесник
Узраст од 12 до 18 · Оба пола · Ажурирано 14. 11. 2025. · NCT06691867Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Augusta University, Augusta
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 22. 6. 2025. · NCT06385886Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.